1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
RHON-KLINIKUM AG Unsponsored ADR

RHON-KLINIKUM AG Unsponsored ADR

RKAGY
RHON-KLINIKUM AG Unsponsored ADRUS flagOther OTC
8.16
USD
- -
- -
1.09BMarket Cap
RHON-KLINIKUM AG Unsponsored ADR
RKAGY
(Other OTC)

Recent

price

8.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
8.39
9.23
9.51
10.36
10.9
5.77
7.69
8.79
9.05
9.21
9.74
10.16
10.47
10.8
10.94
11.92
12.5
Revenue per Share
0.48
0.51
0.56
0.33
0.31
4.68
0.59
0.42
0.26
0.37
0.32
0.01
0.21
0.19
0.29
0.32
0.28
Basic EPS, GAAP
-0.27
-0.37
-0.23
-0.2
0.16
-0.17
-0.06
-0.03
-0.27
-0.85
-0.5
0.12
0.15
0.02
0.35
0.43
- -
Free Cash Flow per Basic Share
0.13
0.15
0.18
0.23
0.13
0.13
0.41
0.4
0.17
0.11
0.14
- -
- -
- -
0.07
- -
- -
Dividend per Share
1.25
1.25
1.25
1.25
1.25
0.7
1.16
1.25
1.25
1.25
1.25
1.25
1.25
1.25
1.25
1.25
1.24
Book Value per Share
3.91
4.15
4.46
4.25
5.44
4.14
6.54
7.02
7.1
7.34
7.53
7.53
7.79
8.01
8.25
8.61
8.65
Tangible Book Value per Share
276
276
276
276
276
262
144
134
134
134
134
134
134
134
134
134
135
Basic Weighted Avg Shares
2,320
2,550
2,629
2,865
3,014
1,511
1,108
1,176
1,211
1,233
1,304
1,360
1,402
1,446
1,464
1,596
1,687
Sales/Revenue/Turnover
7.84
7.76
7.55
5.43
5.58
-0.5
8.97
8.98
4.12
5.24
4.21
-0.06
2.12
2.51
2.02
2.35
2.2
Operating Margin (%)
102
111
143
140
121
82
52
60
59
61
68
70
70
70
66
63
61
Depreciation Expense
132
140
156
90
87
1,226
85
56
35
49
43
1
28
25
39
43
38
Net Income, GAAP
17.05
16.56
13.62
19.06
23.51
1.65
3.15
3.66
1.02
18.98
18
37.36
- -
19.89
15.84
19.57
21.23
Effective Tax Rate (%)
5.67
5.48
5.94
3.15
2.88
81.15
7.7
4.8
2.9
3.97
3.32
0.11
2.02
1.74
2.64
2.72
2.26
Profit Margin (%)
215
264
397
67
1,522
581
252
203
182
237
301
293
338
398
454
499
536
Working Capital
- -
- -
972
773
695
154
14
3
3
104
168
157
156
147
146
115
- -
LT Debt
1,423
1,495
1,599
1,607
1,667
1,249
1,109
1,113
1,125
1,159
1,186
1,190
1,225
1,251
1,280
1,326
1,341
Total Equity
9.87
11.24
8.26
4.75
5.01
-0.39
7.21
8.56
4.45
4.39
3.37
-0.04
- -
2.04
1.73
2.04
2.19
Return on Invested Capital (%)
17.34
41.47
20.21
8.7
8.82
169.97
25.22
32.45
17.25
19.75
13.47
1.42
- -
7.53
11.56
12.77
19.77
Return on Capital (%)
25.4
40.42
45.17
26.08
25.07
463.16
48.63
33.71
21
29.27
25.85
0.87
16.9
15.02
23.12
25.9
22.76
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
67
67
Market Capitalization
723
876
848

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
925
933
935
Cash, Cash Equivalents & STI
619
580
597
Accounts Receivable, Net
239
281
272
Inventories
34
36
36
Total Current Liabilities
411
409
399
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.69%
2.26%
3.57%
Free Cash Flow
268.68%
386.21%
23.81%
Net Income, GAAP
167.12%
361.64%
11.98%
Sales/Revenue/Turnover
1.08%
4.15%
8.99%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
383
393
396
425
1,596
2025
415
419
429
436
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.08
0.07
- -
- -
0.32
2025
0.05
0.05
- -
0.1
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Indie Ranch Media, Inc. (INDR)
Novo Integrated Sciences, Inc. (NVOS)
LIMES Schlosskliniken AG (LIK.DE)
Concord Healthcare Grp Co Ltd (2453.HK)
Raily Aesthetic Medicine International Holdings Limited (2135.HK)
Apollo Hospitals Enterprise Limited (APOLLOHOSP.BO)
Business
RHÖN-KLINIKUM AG, one of Germany's largest healthcare providers, operates highly specialized maximum- and intermediate-care hospitals offering inpatient, semi-inpatient, and outpatient medical services including acute care, rehabilitation, emergency treatment, cardiology, surgery, neurology, orthopedics, psychiatry, and physical therapy; it manages five key hospital sites—Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Giessen und Marburg (UKGM), and Zentralklinik Bad Berka—along with medical care centers, focusing on cross-sector care tied to university research and innovation in digital health such as AI-driven patient assessments and high-speed telematics infrastructure. Founded in 1973 and headquartered in Bad Neustadt an der Saale, Germany, the company serves patients primarily in Bavaria, Hesse, and other regions through its approximately 18,000 employees, emphasizing sustainability, diversity, and the HOUSE OF BEST CARE concept for staff and patient outcomes. In recent developments, RHÖN-KLINIKUM AG reports solid financial performance for 2024 with revenues up 9.0% to 1.60 billion euros and consolidated profit at 45.2 million euros, alongside ongoing investments under the White Paper Plus agreement with Hesse totaling around 850 million euros by 2032 for modernizing UKGM facilities including surgery wings and psychiatry clinics; CEO Prof. Dr. Tobias Kaltenbach departed the Board of Management as planned in early 2025, while the company advances digital initiatives like the DokPro AI emergency system and received Germany's first high-speed connector license from Gematik in 2024, and continues strategic affiliation with the Asklepios Kliniken Group following the 2020 acquisition.

Company News

APIChat

  • defenseworld.net

    RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) Sees Significant Increase in Short Interest